This session will highlight the critical role synthetic biology plays in developing vaccines, a need highlighted by the global health crisis. This conversation will also expand on vaccine development within the cancer community and speak to advancements within personalized medicine. Our expert panel will discuss the latest advancements in synthetic biology that enable faster, more effective vaccine production, crucial for responding to emerging and specialty diseases. This session will also cover various cancer vaccines and the possible use of the N of 1 study. Attendees will gain insights into people designing human vaccines using various bioinformatics tools and learn best practices to get vaccines more rapidly approved through the FDA.